All Amgen Articles
Pharma’s Evolving 2024 Acquisition Spree – $ABBV $EPRX $GILD $JNJ $LLY $MRK $NVS $VRTX
Based on reports from The Wall Street Journal, major pharmaceutical companies are shifting their focus to smaller acquisitions in 2024, with all 17 deals announced in the first half of the year valued at $5 billion or less, reflecting a changing regulatory landscape and a more selective approach to ...
Aug 21, 2024
View Article
Amgen’s Quarterly Results Show Surge In Sales & Profit – $AMGN $DIA $IBB $LTRN
Amgen (AMGN) has reported increased quarterly profit driven by robust sales of treatments for conditions like cholesterol and osteoporosis, among other drugs. The biotech firm, which has slightly adjusted its expectations for full-year revenue and profit upwards, has noted that it anticipates the Ho...
Aug 31, 2023
View Article
Amgen Sues Novartis Subsidiary Sandoz Over Alleged Patent Infringement – $AMGN $NVS $XBI $IBB
Reportedly, Amgen Inc. (AMGN) has taken legal action against Sandoz, a subsidiary of Novartis AG (NVS), in New Jersey federal court. The healthcare giant has accused Sandoz of violating several patents by creating biosimilar versions of its profitable bone-strengthening drugs, Prolia and Xgeva. Am...
May 05, 2023
View Article
Amgen Appeals To Supreme Court To Revive Repatha Patents – $AMGN $DIA $IBB $XB $SNY $REGN $INVO
Reportedly, in the coming week, the U.S. Supreme Court will hear Amgen Inc's appeal to revive patents for its Repatha cholesterol-lowering drug. This comes after a lower court invalidated two of Amgen's patents in a legal dispute with Sanofi SA (SNY)) and Regeneron Pharmaceuticals Inc. (REGN) Amgen ...
Apr 04, 2023
View Article
Amgen Increasing Job Cuts Amid Industry Pressure – $AMGN $DIA $INVO
According to reports, Amgen Inc. (AMGN) has declared that it will cut 450 jobs, which accounts for less than 2% of the company's entire workforce. This is the second time this year that the company is implementing layoffs due to the challenges of increasing drug prices and inflation. The decision to...
Mar 22, 2023
View Article
Stay Informed. Stay Competitive.
Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly and quarterly investing ideas, strategies, and marketing insights.
We value your privacy and will never share your information.
